Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001968582-25-000013
Filing Date
2025-01-02
Accepted
2025-01-02 16:39:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 12993
  Complete submission text file 0001968582-25-000013.txt   14400
Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Subject) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41359 | Film No.: 25502602
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12750 HIGH BLUFF DRIVE, SUITE 475 SAN DIEGO CA 92130
Business Address
Chuang Hao-Yuan (Reporting) CIK: 0001992008 (see all company filings)

Type: 144